Topic: Compensation Package
The place to be in drug sales is biotech, at least if you're judging by pay. Biotech reps outearn pharma reps by almost $40,000 on average.
Some powerful institutional investors are steamed about Mylan Chairman Robert Coury’s $97 million in compensation, and they want him voted out.
It was a solid year for big biotech Amgen and for its CEO, Robert Bradway, who saw his total compensation package get a $750,000 boost to a total of $16.85 million.
For most people who serve as non-executive board members, it’s a part-time job. For board members of Regeneron and Vertex, it’s an extremely lucrative part-time job.
It's for richer and for poorer in the biopharma sales business. Pharma salespeople's pay ranks among the lowest in medical sales, while biotech beats the rest.